SUSAN OUELLETTE: Open Payments
NPI 1720164320 · WOODSTOCK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$159 in 7 payments from 5 companies in 2025. Trend: 2023 $156 · 2024 $23 · 2025 $159
Food & beverage: $159
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Alkermes, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
Products named: Qelbree, COBENFY, CAPLYTA, ARISTADA, TRINTELLIX.
Industry payments across MD — which companies pay providers there.
